The 4th Subcommittee on Pharmaceuticals Development

Agenda

1. Exchange of Opinions on Drug Development
   • DSANJ's Efforts and Towards Construction of Ecosystem Linking Academia and Pharmaceutical Companies Under AMED Leadership
     (Dr. Toru Yoshikawa, Supervisor, Drug Seeds Alliance Network Japan (DSANJ), Osaka Chamber of Commerce and Industry)
   • Expectation for Academia Drug Discovery Based on Drug Discovery Experience and DSANJ Activities in Industry and Academia
     (Dr. Zenichi Terashita, Senior Advisor, Drug Seeds Alliance Network Japan (DSANJ), Osaka Chamber of Commerce and Industry)
   • Lessons Learned from the Experience of Academia Drug Discovery and Future Prospects
     (Dr. Jun Kunisawa, a Member of the Subcommittee)
   • National Institute of Biomedical Innovation in Drug Discovery Support Network (DDSN)
     (Dr. Mitsuo Nagata, Director, Department of Research and Development, National Institutes of Biomedical Innovation, Health and Nutrition)
2. Points to Consider and Future Plan

List of Handouts

• Document 1　Revised edition of Points to Consider on Report (Draft)
• Document 2　The 3rd Subcommittee Minutes Summary
• Document 3　Lecture Materials (Dr. Toru Yoshikawa and Dr. Zenichi Terashita)
• Document 4　Lecture Materials (Dr. Jun Kunisawa, a Member)
• Document 5　Lecture Materials (Dr. Mitsuo Nagata)
• Ref.1　Glossary